Search

Search Constraints

You searched for: Author/Creator Jansky, Petr

Search Results

1. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. Issue 222 (February 2023)

2. Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data. (27th October 2021)

3. Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome. Issue 18 (24th June 2015)

5. Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide. Issue 1 (14th July 2017)

6. Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial. (20th September 2022)

7. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Issue 10193 (13th July 2019)

8. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Issue 10193 (13th July 2019)

9. Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial. Issue 4 (24th January 2022)

10. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Issue 10193 (13th July 2019)